Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

1.

β-blockers: a review of their pharmacological and physiological diversity in hypertension.

Ripley TL, Saseen JJ.

Ann Pharmacother. 2014 Jun;48(6):723-33. doi: 10.1177/1060028013519591. Epub 2014 Mar 31. Review.

PMID:
24687542
[PubMed - indexed for MEDLINE]
2.

Photo-Fenton decomposition of β-blockers atenolol and metoprolol; study and optimization of system parameters and identification of intermediates.

Veloutsou S, Bizani E, Fytianos K.

Chemosphere. 2014 Jul;107:180-6. doi: 10.1016/j.chemosphere.2013.12.031. Epub 2014 Feb 28.

PMID:
24589299
[PubMed - indexed for MEDLINE]
3.

Treatment of hypertension in peripheral arterial disease.

Lane DA, Lip GY.

Cochrane Database Syst Rev. 2013 Dec 4;12:CD003075. doi: 10.1002/14651858.CD003075.pub3. Review.

PMID:
24307487
[PubMed - indexed for MEDLINE]
4.

Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy.

Braun LA, Rosenfeldt F.

Int J Clin Pract. 2013 Aug;67(8):717-25. doi: 10.1111/ijcp.12040. Epub 2012 Dec 26. Review.

PMID:
23279674
[PubMed - indexed for MEDLINE]
5.

Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?

Self TH, Wallace JL, Soberman JE.

J Asthma. 2012 Nov;49(9):947-51. doi: 10.3109/02770903.2012.719252. Epub 2012 Sep 13.

PMID:
22974249
[PubMed - indexed for MEDLINE]
6.

HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey.

Yilmaz B, Arslan S, Asci A.

J Chromatogr Sci. 2012 Nov-Dec;50(10):914-9. doi: 10.1093/chromsci/bms090. Epub 2012 Jun 19.

PMID:
22718748
[PubMed - indexed for MEDLINE]
Free Article
7.

Use of carvedilol in hypertension: an update.

Leonetti G, Egan CG.

Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Review.

PMID:
22661898
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Vasodilating versus first-generation β-blockers for cardiovascular protection.

Fares H, Lavie CJ, Ventura HO.

Postgrad Med. 2012 Mar;124(2):7-15. doi: 10.3810/pgm.2012.03.2532. Review.

PMID:
22437211
[PubMed - indexed for MEDLINE]
9.

Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.

Signorovitch JE, Samuelson TM, Ramakrishnan K, Marynchenko M, Wu EQ, Blum SI, Ramasamy A, Chen S.

Curr Med Res Opin. 2012 Apr;28(4):591-9. doi: 10.1185/03007995.2012.668495. Epub 2012 Mar 16.

PMID:
22352883
[PubMed - indexed for MEDLINE]
10.

Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.

DiNicolantonio JJ, Hackam DG.

Expert Rev Cardiovasc Ther. 2012 Jan;10(1):13-25. doi: 10.1586/erc.11.166. Review.

PMID:
22149523
[PubMed - indexed for MEDLINE]
11.

Determination of atenolol in human urine by gas chromatography-mass spectrometry method.

Yilmaz B, Arslan S.

J Chromatogr Sci. 2011 May;49(5):365-9.

PMID:
21549027
[PubMed - indexed for MEDLINE]
Free Article
12.

β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.

Massarsky A, Trudeau VL, Moon TW.

J Exp Zool A Ecol Genet Physiol. 2011 Jun 1;315(5):251-65. doi: 10.1002/jez.672. Epub 2011 Mar 1. Review.

PMID:
21370487
[PubMed - indexed for MEDLINE]
13.

Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.

Fonseca V, Sharma PP, Shah M, Deedwania P.

Curr Med Res Opin. 2011 Apr;27(4):799-807. doi: 10.1185/03007995.2011.555477. Epub 2011 Feb 10.

PMID:
21306286
[PubMed - indexed for MEDLINE]
14.

Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension.

Heffernan KS, Suryadevara R, Patvardhan EA, Mooney P, Karas RH, Kuvin JT.

Clin Cardiol. 2011 Jan;34(1):39-44. doi: 10.1002/clc.20841.

PMID:
21259277
[PubMed - indexed for MEDLINE]
15.

[Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver].

Mikheeva OM, Drozdov VN, Komisarenko IA.

Ter Arkh. 2011;83(12):49-55. Russian.

PMID:
22416445
[PubMed - indexed for MEDLINE]
16.

Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

McGill JB.

Vasc Health Risk Manag. 2010 Jun 1;6:363-72. Review.

PMID:
20539838
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Determination of metoprolol in human plasma and urine by high-performance liquid chromatography with fluorescence detection.

Yilmaz B, Asci A, Arslan S.

J Sep Sci. 2010 Jul;33(13):1904-8. doi: 10.1002/jssc.201000136.

PMID:
20512810
[PubMed - indexed for MEDLINE]
18.

Gas chromatography-mass spectrometry method for determination of metoprolol in the patients with hypertension.

Yilmaz B, Arslan S, Akba V.

Talanta. 2009 Nov 15;80(1):346-51. doi: 10.1016/j.talanta.2009.06.079. Epub 2009 Jul 8.

PMID:
19782235
[PubMed - indexed for MEDLINE]
19.

An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.

Bakris G.

J Cardiovasc Pharmacol. 2009 May;53(5):379-87. doi: 10.1097/FJC.0b013e31819fd501. Review.

PMID:
19454898
[PubMed - indexed for MEDLINE]
20.

[Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].

Lazebnik LB, Mikheeva OM, Drozdov VN, Petrakov AV, Sil'vestrova SIu.

Eksp Klin Gastroenterol. 2008;(2):22-6. Russian. No abstract available.

PMID:
19148988
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk